Derek Lomas

Urologist at Mayo Clinic. Opinions are my own, not Mayo’s. Following ≠ endorsement.

[Mayo Clinic Urology @MayoUrology]

Mayo Clinic Urology was honored to host visiting professor Dr. Hashim Ahmed for a discussion on advances in prostate cancer screening, precision diagnosis, and focal therapy.
#ProstateCancer #FocalTherapy @imperialcollege @LondonProstate1 @SBoorjian @DerekLomas

[Derek Lomas @DerekLomas]

Day 1 at #JUA2026 in Kyoto 🇯🇵

Outstanding JUA/AUA joint symposium today, with excellent talks by Dr. Eastham and Dr. Sandhu. Looking forward to the rest of JUA and the concurrent International Symposium on Focal Therapy.

@AmerUrological @jua_2026 @FocalSociety

[Mayo Clinic Urology @MayoUrology]

🚨 Join us TODAY at #WCET2025
🗓️Tuesday, Sept 9
⏰5–6 PM
📍103 B
Focal Therapy for Prostate Cancer: Learn patient selection, technologies, post-treatment monitoring & real-world cases. Led by experts from @FocalSociety
@DerekLomas & @DFrendl
#ProstateCancer #Urology

[Derek Lomas @DerekLomas]

@MayoUrology @FocalSociety @dfrendl @Endo_Society Clarification for everyone. Location is actually room 103B. The online schedule and app are incorrect, correct room is listed in the printed meeting schedule.

[Ram Pathak, M.D. @RamPathakMD]

While in town for the #WCET25 @Endo_Society meeting, @DerekLomas and I had to stop by @MayoUrology Arizona and observe @dfrendl perform two IRE cases. A true tri-site collaboration. Thankful for this opportunity.

[Imperial Prostate @IP_London]

Fantastic to see a full house at the @FocalSociety session with @RSanchez_Salas leading the way #AUA25 🇺🇸

We had a fantastic joint #IPFTSMasterclass2025 in London two weeks ago - here is to ongoing trans-Atlantic collaboration!

[Derek Lomas @DerekLomas]

@SBoorjian highlights updates to AUA Microhematuria guidelines at #AUA2025 for INTERMEDIATE Risk group

-Women cannot be high risk based on age only

-Should RECOMMEND Cysto + US

-May offer urine cytology/tumor markers to help decide on cysto

-Persistent microhematuria →cysto

[Derek Lomas @DerekLomas]

@SBoorjian highlights updates to AUA Microhematuria guidelines at #AUA2025 for INTERMEDIATE Risk group

-Women cannot be high risk based on age only

-Should RECOMMEND Cysto + US

-May offer urine cytology/tumor markers to help decide on cysto

-Persistent microhematuria →cysto

[Derek Lomas @DerekLomas]

Compelling arguments by @LondonProstate1 at the Focal Therapy crossfire debate at #AUA2025

-Treatment side effects are reduced 5-10 fold

-Iso-effective to radical therapy at 5-10 year

-Focal therapy should be offered as a standard option for (eligible) intermediate patients

[Derek Lomas @DerekLomas]

Thanks @LondonProstate1 and @IP_London for another fantastic meeting! So great to connect with old friends and make new ones.

[Imperial Prostate @IP_London]

Thank you for engaging with us this year at the first joint #IPFTSmasterclass - see you in London in 2026! @FocalSociety

[Derek Lomas @DerekLomas]

Packed room for the start of the Imperial Prostate & Focal
Therapy Society Masterclass! Great to be back in London! #IPFTSMasterclass25 @FocalSociety

[Candace Granberg, MD @candacegranberg]

Great talk on #AI in the OR by @abhinav__khanna at @MNUrological
🤔 Can it estimate bladder tumor size?
🔢 Assist with tasks like counting instruments?
👩🏻‍⚕️Assess surgical skills, incorporate into education
😱 Will robots replace surgeons??!

Tip of the iceberg!

[Derek Lomas @DerekLomas]

POSTER 2) Among men undergoing MR fusion prostate biopsy for unilateral PIRADS 3 or
4 lesions, transperineal biopsy resulted in greater disease detection for both targeted fusion and systematic samples. TP biopsy may provide a more thorough pre-treatment assessment for FT.

[Derek Lomas @DerekLomas]

@MayoUrology with two posters at #FOCAL2024 POSTER 1) Those are active surveillance with PIRADS 5 lesions disease have lower rates of high-grade disease on targeted biopsy, compared to those with no previous prostate cancer diagnosis. @dfrendl

[Katy @EngineerToTheKT]

Very interesting opening of afternoon Focal Therapy Session by Dr. Herbert Lepor! Patient Selection with @DerekLomas and Energy Selection with @ALDCAbreu covered A LOT of ground. Are we ready for #PrimeTime?! Respect to @mbrothberg for tying in my favorite coach @DeionSanders. Clearly @RubenOlivaresG had momentum in the this focal room…@AbhinavSidana enjoyed panel. #Focal2024 @therapy_focal @arvinkgeorge

Now what in the heck is this Balloon Debate?!? 🎈

[FOCAL+ 2025 @therapy_focal]

#FOCAL2024 is finally here! Don't forget to follow all of our incredible Faculty:
@arvinkgeorge @AbhinavSidana @ALDCAbreu @AnractJulien @Cacciamani_MD @ChughtaiMD @DrJohnMDiBi @aherati @JuanDesLogesMD @veerukasi @amirlebastchi @LoebStacy @dereklomas @DrRanaMcKay @RubenOlivaresG @PeterPintoMD @ArunRaiMD @mbrothberg @Rowe_NuclearMed @DrilyaSobol1 @alantanmd @radiolobt @vermasadhna @Dr_KevinZorn #FocalTherapy

[Derek Lomas @DerekLomas]

Had a great time at the @MNUrological fall meeting in Duluth. It was great to connect with colleagues from across the state, including several @MayoUrology alums. After my talk, it was great to take in the views as we cruised on Lake Superior and through Duluth Harbor.

[Sarah Eggleston @saraheggles]

Today’s @MNUrological meeting had it all!
⚡️ Great talk about focal therapy for prostate cancer from @DerekLomas
👨‍⚕️ Catching up with @drvandersteen
🍁 Fall colors (and a boat ride!) in Duluth Harbor

[Derek Lomas @DerekLomas]

@LanceMynderse from @MayoUrology giving an excellent talk on Complications of Focal Therapy including how to manage and avoid them at @FocalSociety meeting.

[Derek Lomas @DerekLomas]

@LondonProstate1 @IP_London @imperialurology @FocalSociety @BSoT_UK @Uroweb @EAUrf @EAUYAUrology @eau_yuo @EAU_YAUroTech @USANZUrology @urologytraining Excellent opportunity! Highly recommend!

[Derek Lomas @DerekLomas]

Had a great time at the #ipmasterclass24! Great programme and good to see so many friends and colleagues. Was even able to sneak in a little sightseeing around London with @dfrendl!